Depletion of both CD8+ T and NK cells largely reversed tumor growth (Fig. 6J) and mice survival (Fig. 6K) in response to DSF/Cu and anti-PD-1 combination therapy, suggesting that CD8+ T and NK cells are key effectors of the observed antitumor response. This evidence concerns the gene CD8A and neoplasm.